HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

Lobbying for LEGEND BIOTECH CORPORATION · Biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $90,000.00 income · posted Jul 15, 2026

Lobbying activity 1

Health Issues

Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.